Advertisement

Comparison of IL-1β, TNF-α, hBD-2, and hBD-3 Expression in the Dental Pulp of Smokers Versus Nonsmokers

Published:October 21, 2017DOI:https://doi.org/10.1016/j.joen.2017.08.017

      Abstract

      Introduction

      To date, the endodontic literature lacks research on the effect of smoking on cytokine and defensin expression in the dental pulp. Therefore, the aim of this study was to investigate the expression of interleukin (IL)-1β, tumor necrosis factor (TNF)-α, human beta defensin (hBD)-2 and hBD-3 in the dental pulp of smokers and compare them with nonsmokers. We hypothesized that cytokine and defensin expression would be reduced in smokers as compared with nonsmokers.

      Methods

      Thirty-two smokers and 37 nonsmokers with endodontic pulpal diagnoses of normal, symptomatic irreversible pulpitis and asymptomatic irreversible pulpitis were included in this cross-sectional study. Samples from pulp chambers were collected and stored in phosphate-buffered saline at −80°C. Luminex was used to measure IL-1β and TNF-α levels. The levels of hBD-2 and hBD-3 were measured using enzyme-linked immunosorbent assay. Marker levels were normalized to protein concentrations and data were analyzed using Kruskal-Wallis test, Mann-Whitney U test, and 2-way analysis of variance (α = 0.05).

      Results

      Pulpal concentrations of TNF-α and hBD-2 were significantly lower among smokers (P < .01), whereas no significant difference was observed for IL-1β, or hBD-3. Two-way analysis of covariance revealed that smoking status (P < .001), not endodontic diagnosis (pulpal status), significantly affected TNF-α and hBD-2 levels.

      Conclusions

      This study reported that smokers are immunologically deficient in TNF-α and hBD-2, suggesting that dental pulps of smokers possess limited defense mechanisms, affecting their endodontic prognosis and indicating a cause for their reported inferior outcome.

      Key Words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Endodontics
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Friedman S.
        • Abitbol S.
        • Lawrence H.P.
        Treatment outcome in endodontics: the Toronto study. Phase 1: initial treatment.
        J Endod. 2003; 29: 787-793
        • Ng Y.L.
        • Mann V.
        • Gulabivala K.
        A prospective study of the factors affecting outcomes of nonsurgical root canal treatment: part 1: periapical health.
        Int Endod J. 2011; 44: 583-609
        • Sjogren U.
        • Hagglund B.
        • Sundqvist G.
        • et al.
        Factors affecting the long-term results of endodontic treatment.
        J Endod. 1990; 16: 498-504
        • Pasqualini D.
        • Bergandi L.
        • Palumbo L.
        • et al.
        Association among oral health, apical periodontitis, CD14 polymorphisms, and coronary heart disease in middle-aged adults.
        J Endod. 2012; 38: 1570-1577
        • Doyle S.L.
        • Hodges J.S.
        • Pesun I.J.
        • et al.
        Factors affecting outcomes for single-tooth implants and endodontic restorations.
        J Endod. 2007; 33: 399-402
        • Krall E.A.
        • Abreu Sosa C.
        • Garcia C.
        • et al.
        Cigarette smoking increases the risk of root canal treatment.
        J Dent Res. 2006; 85: 313-317
        • Segura-Egea J.J.
        • Castellanos-Cosano L.
        • Velasco-Ortega E.
        • et al.
        Relationship between smoking and endodontic variables in hypertensive patients.
        J Endod. 2011; 37: 764-767
        • Kirkevang L.L.
        • Vaeth M.
        • Horsted-Bindslev P.
        • et al.
        Risk factors for developing apical periodontitis in a general population.
        Int Endod J. 2007; 40: 290-299
        • Lopez-Lopez J.
        • Jane-Salas E.
        • Martin-Gonzalez J.
        • et al.
        Tobacco smoking and radiographic periapical status: a retrospective case-control study.
        J Endod. 2012; 38: 584-588
        • Levin L.G.
        • Law A.S.
        • Holland G.
        • et al.
        Identify and define all diagnostic terms for pulpal health and disease states.
        J Endod. 2009; 35: 1645-1657
        • American Association of Endodontists
        Glossary of Endodontic Terms.
        2011 (Available at:) (Accessed July 13, 2015)
        • Martinho F.C.
        • Nascimento G.G.
        • Leite F.R.
        • et al.
        Clinical influence of different intracanal medications on Th1-type and Th2-type cytokine responses in apical periodontitis.
        J Endod. 2015; 41: 169-175
        • Smith P.
        • Krohn R.I.
        • Hermanson G.
        • et al.
        Measurement of protein using bicinchoninic acid.
        Anal Biochem. 1985; 150: 76-85
        • Walker J.M.
        The bicinchoninic acid (BCA) assay for protein quantitation.
        in: The Protein Protocols Handbook. Humana Press, Totowa, NJ2009: 11-15
        • Domthong U.
        • Parikh C.R.
        • Kimmel P.L.
        • et al.
        Assessing the agreement of biomarker data in the presence of left-censoring.
        BMC Nephrol. 2014; 15: 144
        • Klüver E.
        • Schulz-Maronde S.
        • Scheid S.
        • et al.
        Structure-activity relation of human β-defensin 3: influence of disulfide bonds and cysteine substitution on antimicrobial activity and cytotoxicity.
        Biochemistry. 2005; 44: 9804-9816
        • Funderburg N.
        • Lederman M.M.
        • Feng Z.
        • et al.
        Human β-defensin-3 activates professional antigen-presenting cells via Toll-like receptors 1 and 2.
        Proc Natl Acad Sci U S A. 2007; 104: 18631-18635
        • Yang D.
        • Chertov O.
        • Bykovskaia S.
        • et al.
        β-Defensins: linking innate and adaptive immunity through dendritic and T cell CCR6.
        Science. 1999; 286: 525-528
        • Wang W.M.
        • Ye P.
        • Qian Y.J.
        • et al.
        Effects of whole cigarette smoke on human beta defensins expression and secretion by oral mucosal epithelial cells.
        Tob Induc Dis. 2015; 13: 3
        • Madretsma G.S.
        • Donze G.J.
        • van Dijk A.P.
        • et al.
        Nicotine inhibits the in vitro production of interleukin 2 and tumour necrosis factor-alpha by human mononuclear cells.
        Immunopharmacology. 1996; 35: 47-51
        • Matsunaga K.
        • Klein T.W.
        • Friedman H.
        • Yamamoto Y.
        Involvement of nicotinic acetylcholine receptors in suppression of antimicrobial activity and cytokine responses of alveolar macrophages to Legionella pneumophila infection by nicotine.
        J Immunol. 2001; 167: 6518-6524
        • Cesar-Neto J.B.
        • Duarte P.M.
        • de Oliveira M.C.
        • et al.
        Smoking modulates interleukin-6:interleukin-10 and RANKL:osteoprotegerin ratios in the periodontal tissues.
        J Periodontal Res. 2007; 42: 184-191
        • Wolgin M.
        • Liodakis S.
        • Ulrich I.
        • et al.
        Gene expression of human beta defensins-1 and -2 is significantly reduced in non-inflamed keratinized oral tissue of smokers.
        J Dent. 2012; 40: 949-954
        • Herr C.
        • Beisswenger C.
        • Hess C.
        • et al.
        Suppression of pulmonary innate host defence in smokers.
        Thorax. 2009; 64: 144-149
        • Mahanonda R.
        • Sa-Ard-Iam N.
        • Eksomtramate M.
        • et al.
        Cigarette smoke extract modulates human beta-defensin-2 and interleukin-8 expression in human gingival epithelial cells.
        J Periodontal Res. 2009; 44: 557-564
        • Nile C.J.
        • Sherrabeh S.
        • Ramage G.
        • et al.
        Comparison of circulating tumour necrosis factor superfamily cytokines in periodontitis patients undergoing supportive therapy: a case-controlled cross-sectional study comparing smokers and non-smokers in health and disease.
        J Clin Periodontol. 2013; 40: 875-882
        • Ebersole J.L.
        • Steffen M.J.
        • Thomas M.V.
        • et al.
        Smoking-related cotinine levels and host responses in chronic periodontitis.
        J Periodontal Res. 2014; 49: 642-651
        • Toker H.
        • Akpinar A.
        • Aydin H.
        • et al.
        Influence of smoking on interleukin-1beta level, oxidant status and antioxidant status in gingival crevicular fluid from chronic periodontitis patients before and after periodontal treatment.
        J Periodontal Res. 2012; 47: 572-577
        • Ertugrul A.S.
        • Sahin H.
        • Dikilitas A.
        • et al.
        Gingival crevicular fluid levels of human beta-defensin-2 and cathelicidin in smoker and non-smoker patients: a cross-sectional study.
        J Periodontal Res. 2014; 49: 282-289
        • Erdemir E.O.
        • Duran I.
        • Haliloglu S.
        Effects of smoking on clinical parameters and the gingival crevicular fluid levels of IL-6 and TNF-alpha in patients with chronic periodontitis.
        J Clin Periodontol. 2004; 31: 99-104
        • Souto G.R.
        • Queiroz-Junior C.M.
        • Costa F.O.
        • et al.
        Effect of smoking on immunity in human chronic periodontitis.
        Immunobiology. 2014; 219: 909-915
        • Ouyang Y.
        • Virasch N.
        • Hao P.
        • et al.
        Suppression of human IL-1β, IL-2, IFN-γ, and TNF-α production by cigarette smoke extracts.
        J Allergy Clin Immunol. 2000; 106: 280-287
        • Pyatt D.W.
        • Stillman W.S.
        • Irons R.D.
        Hydroquinone, a reactive metabolite of benzene, inhibits NF-kappa B in primary human CD4+ T lymphocytes.
        Toxicol Appl Pharmacol. 1998; 149: 178-184
        • Schröder J.-M.
        • Harder J.
        Human beta-defensin-2.
        Int J Biochem Cell Biol. 1999; 31: 645-651
        • Kim Y.S.
        • Min K.S.
        • Lee S.I.
        • et al.
        Effect of proinflammatory cytokines on the expression and regulation of human beta-defensin 2 in human dental pulp cells.
        J Endod. 2010; 36: 64-69
        • Paris S.
        • Wolgin M.
        • Kielbassa A.M.
        • et al.
        Gene expression of human beta-defensins in healthy and inflamed human dental pulps.
        J Endod. 2009; 35: 520-523
        • Duncan H.F.
        • Pitt Ford T.R.
        The potential association between smoking and endodontic disease.
        Int Endod J. 2006; 39: 843-854
        • Chen C.-P.
        • Hertzberg M.
        • Jiang Y.
        • et al.
        Interleukin-1 and tumor necrosis factor receptor signaling is not required for bacteria-induced osteoclastogenesis and bone loss but is essential for protecting the host from a mixed anaerobic infection.
        Am J Pathol. 1999; 155: 2145-2152
        • Haber J.
        Smoking is a major risk factor for periodontitis.
        Curr Opin Periodontol. 1994; 1: 12-18
        • Bolin A.
        • Eklund G.
        • Frithiof L.
        • et al.
        The effect of changed smoking habits on marginal alveolar bone loss. A longitudinal study.
        Swed Dent J. 1993; 17: 211-216
        • Rodrigues F.M.
        • Ramos D.
        • Xavier R.F.
        • et al.
        Nasal and systemic inflammatory profile after short term smoking cessation.
        Respir Med. 2014; 108: 999-1006
        • Kinane D.F.
        • Chestnutt I.G.
        Smoking and periodontal disease.
        Crit Rev Oral Biol Med. 2000; 11: 356-365